Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.850
-0.130 (-6.57%)
May 29, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $9.58 million as of May 29, 2026.
Market Cap
9.58M
Enterprise Value
3.40M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $9.58M, a decrease of -75.70%. That is a compound annual growth rate of -94.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 9.58M | -72.55% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 39.03M |
| Milestone Scientific | 34.04M |
| Harvard Bioscience | 26.07M |
| Femasys | 22.83M |
| Retractable Technologies | 21.48M |
| Jin Medical International | 17.04M |
| Bionano Genomics | 13.64M |
| Lucyd | 6.43M |